Lewy Body Disease
60
18
21
23
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
1.7%
1 terminated out of 60 trials
95.8%
+9.3% vs benchmark
10%
6 trials in Phase 3/4
35%
8 of 23 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 23 completed trials
Clinical Trials (60)
Retinal Hyperspectral Imaging in Neurodegenerative Diseases
The Swedish BioFINDER Sleep Study
Digital Health Technologies for Progressive Supranuclear Palsy and Dementia With Lewy Bodies
PERSEVERE: Peer Mentor Support and Caregiver Education in Lewy Body Dementia
Longitudinal Imaging Biomarkers of Disease Progression in DLB
18F-DOPA II - PET Imaging Optimization
Language and Lewy Body Diseases: Sentence Comprehension Problems and Modifying Noninvasive Brain Stimulation Treatment
A Study of Neurodegeneration and Neuronal Fluctuations in Lewy Body Disease and Alzheimer's Disease
Dynamical Electrophysiology and Neuropathology in Lewy's Bodies Disease
Relationship Between Alzheimer Disease and Diminution of the Three Macular Nervous Retinal Layers
Stimulation of Cingulo-opercular Alertness Network
tDCS Effect on Psychotic Symptoms in Dementia With Lewy Bodies (DLB), and Impacts on Caregiver Burden
OCT-Angiography and Adaptive Optics in Patients With Memory Impairment
MIBG in Aging and Neurologic Disorders
Promoting Goals-of-Care Discussions for Patients With Memory Problems and Their Caregivers
Telehealth in Lewy Body Dementia
Care of Persons With Dementia in Their Environments (COPE) in Programs of All-Inclusive Care of the Elderly (PACE)
Neurologic Stem Cell Treatment Study
A Relational Research Recruitment and Engagement Intervention for Cognitive Aging Research
The Swedish BioFINDER - Memory Clinic Study